Regulatory and Washington

05/15/2013 - 2:23pm
FDA approves Genentech drug for lung cancer with genetic mutation

The Food and Drug Administration has approved a drug for a type of lung cancer.

05/15/2013 - 12:05pm
FDA approves Mylan migraine drug

The Food and Drug Administration has approved a generic migraine drug made by Mylan, the company said Wednesday.

05/15/2013 - 11:33am
FDA approves new prostate cancer drug

A new treatment for late-stage prostate cancer has received approval from the Food and Drug Administration.

05/15/2013 - 10:03am
CDSC joins NFL wideout Larry Fitzgerald Jr. to educate Congress on value of supplements

The Congressional Dietary Supplement Caucus held an educational briefing, “Sports Health and Fitness: The Role of Dietary Supplements,” for Capitol Hill staff.

05/14/2013 - 3:53pm
Senators call for oversight on preferred pharmacy networks

Medicare Part D plans that create tiered networks of pharmacies for beneficiaries need more oversight amid reports that small and medium-sized pharmacies are being excluded from them, several senators wrote in a letter last week to the Centers for Medicare and Medicaid Services.

05/14/2013 - 3:12pm
Study finds large numbers of students abuse prescription drugs to cope with stress of finals

Finals can be a stressful time for any college or graduate student, with many hours spent studying and few spent socializing or relaxing. But many students are using prescription drugs to get through finals, according to a new study.

05/14/2013 - 11:29am
Actavis seeks FDA approval for contraceptive patch

The Food and Drug Administration will review an experimental contraceptive patch made by Actavis, the drug maker said Tuesday.

05/14/2013 - 11:03am
Actavis issues regulatory filing to comply with Irish company-takeover rules

Actavis is continuing to pursue a plan to buy Irish drug maker Warner Chilcott, as the U.S.-based company announced Tuesday its total number of shares and share-purchase options in order to comply with Ireland's merger-and-acquisition rules.

05/13/2013 - 4:14pm
Temporary stay of Plan B decision extended through May 28

The Food and Drug Administration's temporary stay pending its appeal of a district court decision ordering all levonorgestrel-based emergency contraceptives be available without a prescription and without any age restrictions was extended through May 28 by the U.S. Court of Appeals for the Second Circuit.

05/13/2013 - 3:31pm
N.J. law designed to address prescription eye drop adherence

New Jersey Gov. Chris Christie signed legislation into law that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.

© 2013 Drug Store News. All Rights Reserved.